Sara Buhrlage
0000-0003-4562-1823
5 papers found
Refreshing results…
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma
Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes
Inhibition of the deubiquitinating enzyme USP47 as a novel targeted therapy for hematologic malignancies expressing mutant EZH2
Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell Lymphoma
Advances in Discovering Deubiquitinating Enzyme (DUB) Inhibitors
Missing publications? Search for publications with a matching author name.